Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy

Journal of Clinical Pharmacology

Volumn 38, Issue 6, 1998, Pages 502-509

  Lawson, George M ^a   Hurt, Richard D ^a   Dale, Lowell C ^a   Offord, Kenneth P ^a   Croghan, Ivana T ^a   Schroeder, Darrell R ^a   Jiang, Nai S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; NICOTINE;

ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SMOKING; SMOKING CESSATION; TRANSDERMAL DRUG ADMINISTRATION; TRANSDERMAL PATCH;

EID: 0031801598     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb05787.x     Document Type: Review

References (24)

1. Abelin T, Ehrsam R, Buhler-Rechert A: Effectiveness of a transdermal nicotine system in smoking cessation studies. Methods Find Exp Clin Pharmacol 1989;11:205-214.
2. Hurt RD, Lauger GG, Offord KP, Kottke TE, Dale LC: Nicotine replacement therapy with use of a transdermal patch: a randomized double-blind placebo-controlled trial. Mayo Clin Proc 1990; 65:1529-1537.
3. Rose JE, Levin ED, Behm FM, Adivi C, Schur C: Transdermal nicotine facilitates smoking cessation. Clin Pharmacol Ther 1990; 47:323-330.
4. Tonneson P, Norregard J, Simonsen K: A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991;325:311-315.
5. Transdermal Nicotine Study Group: Transdermal nicotine for smoking cessation: six-month results from two multicenter controlled clinical trials. JAMA 1991;266:3133-3138.
6. Sachs DPL, Sawe U, Leischow SJ: Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting without intensive group counseling. Arch Intern Med 1993;153: 1881-1890.
7. Hurt RD, Dale LC, Fredrickson PA, Caldwell CC, Lee GM, Offord KP, et al: Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up: one-year outcome and percentage nicotine replacement. JAMA 1994;271: 595-600.
8. Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR: High-dose nicotine patch therapy: percentage of replacement and smoking cessation. JAMA 1995;274:1353-1358.
9. Jorenby DE, Smith SS, Fiore MC, Hurt RD, Offord KP, Croghan IT, et al: Varying nicotine patch dose and type of smoking cessation counseling. JAMA 1995;274:1347-1352.
10. Benowitz NL: Pharmacologic aspects of cigarette smoking and nicotine addiction. New Engl J Med 1988;319:1318-1330.
11. Benowitz NL: Nicotine replacement therapy: what has been accomplished - can we do better? Drugs 1993;45:157-170.
12. Lawson GM, Hurt RD, Dale LC, Offord KP, Croghan IT, Schroeder DR, et al: Application of urine nicotine and cotinine excretion rates to assess nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. J Clin Pharmacol 1998;38:510-516.
13. Hurt RD, Dale LC, Offord KP, Lauger GG, Baskin LB, Lawson GM, et al: Serum nicotine and cotinine levels during nicotine-patch therapy. Clin Pharmacol Ther 1993;54:98-106.
14. Mulligan SC, Masterson JG, Devane JG, Kelly JG: Clinical and pharmacokinetic properties of a transdermal nicotine patch. Clin Pharmacol Ther 1990;47:331-337.
15. Baskin LB, Charlson JR, Hurt RD, Lawson GM: Determination of serum nicotine concentration using solid-phase extraction, gas chromatography/mass spectrometry with selected ion monitoring and a deuterated nicotine internal standard (abstract). Clin Chem 1991;37:467.
16. Baskin LB, Anderson RW, Charlson JR, Hurt RD, Lawson GM: Determination of nicotine in serum and urine by isotope dilution using solid phase extraction and gas chromatography/mass spectrometry with selected ion monitoring. Ann Clin Biochem (in press).
17. Machacek DA, Jiang NS: Quantitation of cotinine in plasma and saliva by liquid chromatography. Clin Chem 1986;32:979-982.
18. Palmer KJ, Buckley MM, Faulds D: Transdermal nicotine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs 1992;44:498-529.
19. Ross HD, Chan KKH, Piraino AJ, John VA: Pharmacokinetics of multiple daily transdermal doses of nicotine in healthy smokers. Pharm Res 1991;8:385-388.
20. 2 nicotine patch under steady-state conditions. Int J Clin Pharmacol Ther Toxicol 1991;29:92-95.
21. Gorsline J, Okerholm RA, Rolf CN, Moos CD, Hwang SS: Comparison of plasma nicotine concentrations after application of Nicoderm (nicotine transdermal system) to different skin sites. J Clin Pharmacol 1992;32:576-581.
22. Bannon YB, Corish J, Corrigan OI, Denone JG, Kavanaugh M, Mulligan S: Transdermal delivery of nicotine in normal human volunteers: a single dose and multiple dose study. Eur J Clin Pharmacol 1989;37:285-290.
23. Dubois JP, Sioufi A, Muller D, Mavli D, Imhof PR: Pharmacokinetics and bioavailability of nicotine in healthy volunteers following single and repeated administration of different doses of transdermal nicotine systems. Methods Find Exp Clin Pharmacol 1989;11:187-195.
24. Benowitz NL, Jacob PJ III: Nicotine and cotinine eliminatory pharmacokinetics in smokers and nonsmokers. Clin Pharmacol Ther 1993;53:316-323.